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IntrOductIOn
Hepatitis C, after hepatitis B, is the second leading viral infectious 
disease worldwide and its significance relates to the development 
of hepatic diseases and the associated complications [1]. The 
prevalence of hepatitis C is about 3% globally and the number 
of infected individuals is estimated about 130-170 million [1-4]. 
This virus is the most prevalent reason for chronic hepatitis, liver 
cirrhosis, and hepatocellular carcinoma in North America, Europe, 
and Japan and the most important reason for liver transplantation in 
the United States [5,6].
In Iran, hepatitis C is the most important and prevalent reason for 
chronic hepatitis and liver cirrhosis in the multi transfused population 
(thalassemia, hemophilia, and hemodialysis). Prevalence of hepatitis 
C is much less than hepatitis B in Iran, so that 0.3% of volunteer 
blood donors (compared with 4% in Egypt, 2.2% in Japan, and 1.4% 
in Africa) and less than 10% of the patients with chronic hepatitis or 
liver cirrhosis in their serum in Tehran, were eligible for anti-hepatitis 
C virus antibodies (HCV Abs) [5]. In most developed countries 
prevalence is under 1%, but in Asian countries the prevalence is 
higher. For example, the prevalence of hepatitis C was reported 
0.3% in Germany [7], 0.06% in North America [8], 2.4% in Lithuania 
[9], 1.2% in Brazil and Libya [10,11], 5.2% in India [12], and 4.8% 
in Pakistan [13]. In Iran, most studies have been conducted on high 
risk populations; the prevalence of hepatitis C was reported 11-25% 
 
in hemodialysis patients, 11-52% in intravenous (IV) drug abusers, 
and 15-76% in hemophilia and thalassemia patients [5,14-17].
The study of blood donors in Iran from 2004 to 2007 reported 
the prevalence 0.13% [18] and the prevalence in blood donors in 
Shahrekord, capital of Chaharmahal and Bakhtiari was reported 
0.6% [19]. However, the prevalence estimated for Iran general 
population was less than 1%, which is less than the countries of 
the region [5]. Some recent, population-based studies confirm 
this finding. The findings of these studies represent the difference 
in population prevalence among different provinces and regions of 
Iran, which could be attributed to the contribution of lifestyle, and 
cultural and ethnicity-related conditions to hepatitis C prevalence 
and the associated risk factors [20-22]. Regarding these differences 
and the limited number of population-based studies on prevalence 
of hepatitis C, and the necessity of conducting such investigation in 
Chaharmahal and Bakhtiari to study the prevalence and risk factors 
of this disease in the community, this population-based study 
was conducted, following the recommendation of the University 
Committee of Hepatitis, to determine the burden of disease and to 
plan for controlling the infection and disease. 
MAterIAls And MethOds
In this analytical, population-based study, adults over 15 years old 
in urban and rural areas of Chaharmahal and Bakhtiari comprise 
the sample population. With confidence interval 95%, relative error 
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ABstrAct
Introduction: Hepatitis C is the second leading viral infectious 
disease worldwide. In Iran, hepatitis C is the most important and 
prevalent reason for chronic hepatitis and liver cirrhosis in the 
multi transfused population.
Aim: This study was conducted to determine seroprevalence and 
burden of hepatitis C in Chaharmahal and Bakhtiari province and 
to plan for controlling it. 
Materials and Methods: For this analytical, population-based 
study, 3000 samples older than 15 years old were enrolled from 
urban and rural areas of Chaharmahal and Bakhtiari province, 
southwest Iran per cluster sampling. Written informed consent 
was obtained from the participants and the demographic data, 
transmission route and risk factors were collected after blood 
sample taking. Hepatitis C virus antibody (HCV Ab) and western 
blotting were consecutively run.
statistical Analysis: Data analysis was done by SPSS 19 using 
descriptive statistics, and chi-square test, Fisher’s exact test, and 
logistic regression Ap value of 0.05 was considered as the level of 
significance.
results: The prevalence of HCV Ab was obtained 1.4% (95% CI, 
0.95-1.7) and that of positive hepatitis C by western blotting 0.9% 
(95% CI, 0.65-1.3). The prevalence in men (1.2%) was obtained 
two times higher than women. The highest prevalence was 
obtained in 35 to 44-year-old population (2%). The prevalence 
was higher in married individuals and less in higher educated. 
History of hospital stay, first degree relatives infected with HCV, 
jaundice, history of blood transfusion, tattoo, outpatient surgery, 
imprisonment, contact with the infected, intravenous (IV) drug 
abuse, and smoking had significant association with disease 
prevalence (p<0.05). The highest odds ratio was obtained for 
history of IV drug abuse (OR=38.2, 95% CI, 14.06-103.9) followed 
by imprisonment (OR=8.9, 95% CI, 2.97-26.6). However, by 
logistic regression only history of IV drug abuse was obtained as 
significant (p<0.05).
conclusion: Hepatitis C is growing and emerging as the most 
prevalent chronic, viral hepatic disease, so further consideration 
of risk factors and routes of transmission is crucial for appropriate 
planning for, and preventing, treating, and controlling hepatitis 
C. IV drug abusers as the most important group need special 
consideration and surveillance in order to cut infection chain 
and decrease the disease incidence. 
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25%, and 800000-individual population of the area under study, 
3000 individuals were enrolled. The method of sampling was 
clustered, consisting of 50 60-individual clusters (32 urban, 18 
rural). The inclusion criteria were 15 years and older, and consent 
to participate. The written consent to enter into the study was 
obtained from the participants to fill out the questionnaire, to take 
blood sample, and generally to observe research ethics. This study 
has ethics code of 90-2-6/1 of Ethics Committee of the University. 
Notably, the sample considered in the present study is similar to 
another study simultaneously approved with similar protocol and 
ethics code [23]. 
Three separate teams were formed for interview, blood sample 
taking, and laboratory to implement the study. Firstly, interview team 
referred houses, explained the purpose of the research project, and 
questioned the presence of qualified individual(s) in the house. If 
the answer was yes and the individual was consent to participate, 
the researchers asked him/her to fill out the questionnaire. For 
seroprevalence of hepatitis, two consecutive tests, HCV Ab and 
western blotting were used. By this way, to confirm the test, positive 
HCV Ab samples were further investigated by western blotting and 
the confirmed samples by western blotting were considered as 
hepatitis C-positive. HCV-Elisa was run with Dia-Pro kit (Italy) and 
western blotting with MP kit. 
stAtIstIcAl AnAlysIs
Having entered the data into SPSS19 software, we did data analysis 
using descriptive parameters, and chi-square and Fisher’s exact 
test, and then significant factors in univariate analysis were entered 
into logistic regression model to eliminate probable confounding 
factors. The level of significance was considered 0.05.
results
Mean age of the participants was 38.4±16.3 (range: 15-90) years 
old. 63% were female and 75% married. Initially, 40 of 3000 were 
HCVAb-positive and after running western blotting, HCVAb-
positive cases declined to 27. Therefore, the prevalence of HCVAb 
was obtained 1.4% (95% CI, 0.95-1.7) and positive hepatitis C 
prevalence by western blotting was 0.9% (95% CI, 0.65-1.3). 
The highest prevalence was obtained in Kiar and Ardal Counties 
(respectively 2.08% and 1.66%) and no positive western blotting 
was derived in Lordegan and Farsan [Table/Fig-1]. The prevalence 
in men was obtained 1.2%, two times higher than the prevalence 
in women. The highest prevalence (2.12%) was obtained in 35-44 
years old population followed by 25-34 years old (0.9%) and 45-54 
years old (0.8%) populations. The prevalence in married individuals 
was obtained 1.22%, two times higher than the prevalence in single 
individuals. The prevalence in Fars ethnicity (1%), civil servants 
(1.9%), non public occupations (1.58%), and the jobless (1.07%) 
was higher than others. The prevalence in cities (0.8%) and villages 
(0.7%) was approximately similar. For education, the highest 
prevalence was obtained in those able to read and the illiterate (1%) 
and as the education grew higher, the prevalence decreased [Table/
Fig-1].
Total 
number
Positive 
Cases 
no. 
(Western 
blotting)
Preva-
lence 
(%)
p-value 
a Chi-
Square
County
0.08 
(Fisher’s 
Exact 
Test)
     Shahrekord 1680 15 0.89
     Boroujen 420 5 1.19
     Farsan 120 0 0
     Lordegan 300 0 0
     Ardal 60 1 1.66
     Kouhrang 180 1 0.55
     Kiar 240 5 2.08
     total 3000
     Missing* 0
Gender
0.08
     Male 1111 14 1.26
     Female 1889 13 0.68
     total 3000
     missing 0
age, years
0.01
     15-24 708 3 0.42
     25-34 766 7 0.91
     35-44 518 11 2.12
     45-54 456 4 0.87
     55-64 384 3 0.78
     >64 161 0 0
     Total 2993
     Missing 7
     Marital status
0.3     Single 717 4 0.55
     Married 2125 23 1.08
     Divorced/Widow 136 0 0
     Total 2978
     Missing 22
     ethnicity
0.04     Fars 1549 19 1.22
     Turk 482 0 0
     Lor 904 8 0.88
     Total 2935
     Missing* 65
     Residence
1     Urban 1847 15 0.81
     Rural 1068 8 0.74
     Nomadic 5 0 0
     Total 2920
     Missing 80
     occupation
0. 1 
(Fisher’s 
Exact 
Test)
     Civil Servant 151 3 1.98
     Non-Public 506 8 1.58
     Student 340 0 0
     Soldier 12 0 0
     Housewife 1495 12 0.80
     Retired 102 1 0.98
     Jobless 278 3 1.07
     Farmer and 
      poulterer
92 0 0
     Total 2976
     Missing* 24
     education
0.1
     Illiterate 629 6 0.95
     Able to read 1069 12 1.12
     Diploma and 
     above
1010 6 0.59
     MA/MSc and 
     above
268 1 0.37
     Total 2976
     Missing* 24
[table/Fig-1]: Prevalence of hepatitis C for demographic characteristics 
a At 0.05 level, p is significant
* Some items in questionnaire were not completed by all the participants
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Risk factor Total number Positive Cases
 number
Prevalence% oR a Ci p-value b Chi-
Square
hospitalization history
0.02
Yes 1595 19 1.19
6.7 1.06-4.3
No 1344 6 0.44
Total 2939
Missing* 61
Jaundice history
0.04
Yes 43 2 4.65
6.3 1.43-27.7
No 2868 22 0.76
Total 2911
Missing* 89
First degree relative, infected with virus
0.04
Yes 93 3 3.22
4.1 1.2-13.9
No 2871 23 0.80
Total 2964
Missing* 36
Transfusion history
0.03
Yes 72 3 4.16
5.42 1.59-18.5
No 2894 23 0.79
Total 2966
Missing* 34
Tattoo
0.002
Yes 307 9 2.9
4.68 2.06-10.5
No 2651 17 0.64
Total 2958
Missing* 42
outpatient surgery history
0.002
Yes 514 11 2.1
3.55 1.62-7.7
No 2450 15 0.61
Total 2964
Missing* 36
Contact with the infected
0.01
Yes 120 4 3.3
4.6 1.55-13.7
No 2824 21 0.74
Total 2944
Missing* 56
imprisonment
0.002
Yes 63 4 6.3
8.9 2.97-26.6
No 2912 22 0.75
Total 2975
Missing* 25
iV drug abuse
0.005
Yes 29 6 20.68
38.2 14.06-103.9
No 2952 20 0.67
Total 2981
Missing* 19
Smoking
6.26 2.8-13.6 0.03
Yes 417 13 3.1
No 2545 13 0. 51
Total 2962
Missing* 38
[table/Fig-2]: Prevalence of hepatitis C for risk factors 
a Abbreviations: OR, odds ratio; CI, confidence interval.
b At 0.05 level, p is significant.
* Some items in questionnaire were not completed by all the participants
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Chi-square indicated that out of the risk factors and the factors 
contributing to the transmission, history of hospital stay and 
jaundice, first degree relatives infected with HCV, and history of 
blood transfusion, tattoo, outpatient surgery, contact with hepatitis-
infected individuals, imprisonment, intravenous (IV) drug abuse, and 
smoking were significantly associated with the disease prevalence. 
The highest odds ratio was obtained for history of IV drug abusers 
(OR=38.2, 95% CI, 14.06-103.9) followed by imprisonment 
(OR=8.9, 95%CI, 2.97-26.6) [Table/Fig-2]. However, by logistic 
regression (enter model), out of the above factors, only history of IV 
drug abuse was obtained as significant (p< 0.05).
dIscussIOn 
In this study, the prevalence of HCV Ab was obtained 1.4% and 
that of positive hepatitis C by western blotting was obtained 0.9% 
in Chaharmahal and Bakhtiari. The prevalence of hepatitis C has 
been already studied in high risk populations, but few studies 
have been conducted as population-based. A population-based 
study investigated prevalence of hepatitis C in three provinces in 
northern, central, and southern Iran; the general prevalence was 
reported 0.5%, and the prevalence in Golestan 1%, in Tehran 0.3%, 
and in Hormozgan 1.6% [20]. In a population-based study in Amol 
(Mazandaran province), the prevalence of hepatitis C was obtained 
0.05% [21], and in another study in Zahedan 0.5% [22].
By the findings of a study, the prevalence of hepatitis C, similar to 
hepatitis B, was heterogenous and varied depending on cultural, 
ethnicity-related conditions and lifestyle among provinces [24]. 
Although the population-based prevalence of hepatitis B in 
Chaharmahal and Bakhtiari has been already obtained 1.3% [24], 
which is lower than national prevalence, but hepatitis C prevalence 
was higher than the general, national prevalence obtained in Merat et 
al., study [20]. Therefore, it seems that hepatitis C is being replaced 
as and turned into the most prevalent chronic, viral hepatic disease, 
which highlights greater emphasis on and necessity of appropriate 
planning for preventing, treating, and controlling it. This has been 
already confirmed by some studies in Iran and other countries 
[8,20].
In the present study, the prevalence was twice higher in men than 
women, which is consistent with most studies in Iran and other 
countries, and possibly attributable to more risk factors in men. 
The highest prevalence was obtained in 35-44 years old population 
followed by 25-34 years old and 45-54 years old populations. In 
similar studies, the prevalence was higher in older populations, 
as well [8-12]. The prevalence was obtained higher in married 
individuals than single, and lower in Turk and Lor populations than 
Fars. This could be due to different lifestyle and less frequent high 
risk behaviors. Study of the association between ethnicity and 
hepatocellular carcinoma could be helpful in this regard.
The occupations most involved were non-public, civil servants, and 
jobless. The prevalence was not much different between cities and 
villages. In a study in Pakistan, the prevalence was obtained higher 
in 20-49 years old population and was not different between men 
and women. The prevalence has been already reported higher in 
married individuals, the individuals with public and outside home 
occupations and low socioeconomic status [13], consistent with the 
present study. The prevalence was higher in the individuals with the 
education level lower than diploma. In other similar investigations, 
consistent with the present study, the prevalence was less in the 
individuals with higher education [8-13], which is due to enhanced 
knowledge, attitude, and practice in these individuals.
Out of the risk factors and the factors contributing to the transmission, 
hospital stay history, first degree relatives infected with HCV, and 
history of blood transfusion, tattoo, outpatient surgery, contact with 
hepatitis-infected individuals, imprisonment, IV drug abuse, and 
smoking were significantly associated with disease prevalence, 
which is consistent with other studies [5-20]. However, by logistic 
regression, only history of IV drug abuse was yielded as significant. 
Probably, imprisonment and smoking were not significant in the 
model due to association with IV drug abuse. In study of Iran’s three 
provinces, imprisonment and IV drug abuse were the main factors 
in the model [18]. In study of Amol, Mazandaran province, unsterile 
puncture and infection in first degree relatives were obtained as 
the main risk factors in the model [19], but in study of Zahedan, 
none of the risk factors were obtained as significant in multivariate 
analysis [20]. In this province, the highest odds ratio was obtained 
for IV drug abuse, so IV drug abuse seems to be the main factor. 
But, difference in ethnicity and probable effect of lifestyle should be 
considered, as well.
cOnclusIOn
It seems that hepatitis C is growing as the most prevalent chronic, 
viral hepatic disease. Further consideration of risk factors and 
routes of infection transmission is crucial for appropriate planning 
for, and preventing, treating, and controlling hepatitis C. IV drug 
abusers as the most important group need special consideration 
and surveillance in order to cut infection chain and decrease the 
disease incidence.    
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